Ownership history in Parallel Advisors, LLC · 3 quarters on record
This page tracks every 13F SEC filing in which Parallel Advisors, LLC reported a position in CERO THERAPEUTICS HLDGS INC WT EXP 021329 (CEROW). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 27,500 | -22,500 | -45.0% | 0.00% | $366 | — |
| 2025 Q2 | UNCHANGED | 50,000 | — | 0% | 0.00% | $1K | — |
| 2025 Q1 | INITIATED | 50,000 | — | — | 0.00% | $725 | — |